E. J. Aspinall, D. Nambiar, D. J. Goldberg, M. Hickman, A. Weir et al., Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis, Int J Epidemiol, vol.43, pp.235-283, 2014.

L. Gowing, M. F. Farrell, R. Bornemann, L. E. Sullivan, and R. Ali, Oral substitution treatment of injecting opioid users for prevention of HIV infection, Cochrane Database Syst Rev, vol.10, p.4145, 2011.

J. Emmanuelli and J. Desenclos, Harm reduction interventions, behaviours and associated health outcomes in France, Addiction, vol.100, pp.1690-700, 1996.

M. Jauffret-roustide, J. Pillonel, L. Weill-barillet, L. Léon, Y. L. Strat et al., Estimation of HIV and hepatitis C prevalence among drug users in France-First results from the ANRS-Coquelicot, Survey. Bull Epidemiol Hebd, pp.504-513, 2011.

M. A. Blome, P. Bjorkman, L. Flamholc, H. Jacobsson, V. Molnegren et al., Minimal transmission of HIV despite persistently high transmission of hepatitis C virus in a Swedish needle exchange program, J Viral Hepatol, vol.18, pp.831-840, 2010.

B. Somaini, J. Wang, M. Perozo, F. Kuhn, D. Meili et al., A continuing concern: HIV and hepatitis testing and prevalence among drug users in substitution programmes in, AIDS Care, vol.12, pp.449-60, 2000.

M. J. Alter, Epidemiology of hepatitis C virus infection, World J Gastroenterol, vol.13, pp.2436-2477, 2007.

N. Palmateer, S. Hutchinson, G. Mcallister, A. Munro, S. Cameron et al., Risk of transmission associated with sharing drug injecting paraphernalia: analysis of recent hepatitis C virus (HCV) infection using cross-sectional survey data, J Viral Hepatol, vol.21, pp.25-32, 2014.

P. K. Nelson, B. M. Mathers, B. Cowie, H. Hagan, D. Jarlais et al., Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews, Lancet, vol.378, pp.571-83, 2011.

B. Pieper, R. S. Kirsner, T. N. Templin, and T. J. Birk, Injection drug use: an understudied cause of venous disease, Arch Dermatol, vol.143, pp.1305-1314, 2007.

E. Lloyd-smith, E. Wood, R. Zhang, M. W. Tyndall, S. Sheps et al., Determinants of hospitalization for a cutaneous injection-related infection among injection drug users: a cohort study, BMC Public Health, vol.10, p.327, 2010.

T. Kerr, E. Wood, E. Grafstein, T. Ishida, K. Shannon et al., High rates of primary care and emergency department use among injection drug users in Vancouver, J Public Health (Oxf), vol.27, pp.62-68, 2005.

C. E. Cherubin and J. D. Sapira, The medical complications of drug addiction and the medical assessment of the intravenous drug user: 25 years later, Ann Intern Med, vol.119, pp.1017-1045, 1993.

L. Degenhardt, S. Gilmour, F. Shand, R. Bruno, G. Campbell et al., Estimating the proportion of prescription opioids that is consumed by people who inject drugs in Australia, Drug Alcohol Rev, vol.32, pp.468-74, 2013.

M. Valenciano, J. Emmanuelli, and F. Lert, Unsafe injecting practices among attendees of syringe exchange programmes in France, Addiction, vol.96, pp.597-606, 2001.

P. Del-giudice, Cutaneous complications of intravenous drug abuse, Br J Dermatol, vol.150, pp.1-10, 2004.

R. Dwyer, L. Topp, L. Maher, R. Power, M. Hellard et al., Prevalences and correlates of non-viral injecting-related injuries and diseases in a convenience sample of Australian injecting drug users, Drug Alcohol Depend, vol.100, pp.9-16, 2009.

B. D. Marshall, M. J. Milloy, E. Wood, J. S. Montaner, and T. Kerr, Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study, Lancet, vol.377, pp.1429-1466, 2011.

B. Rachlis, E. Lloyd-smith, W. Small, D. Tobin, D. Stone et al., Harmful microinjecting practices among a cohort of injection drug users in Vancouver, Canada. Subst Use Misuse, vol.45, pp.1351-66, 2010.

P. Mateu-gelabert, M. V. Gwadz, H. Guarino, M. Sandoval, C. M. Cleland et al., The staying safe intervention: training people who inject drugs in strategies to avoid injection-related HCV and HIV infection, AIDS Educ Prev, vol.26, pp.144-57, 2014.

M. E. Mackesy-amiti, L. Finnegan, L. J. Ouellet, E. T. Golub, H. Hagan et al., Peer-education intervention to reduce injection risk behaviors benefits high-risk young injection drug users: a latent transition analysis of the CIDUS 3/DUIT study, AIDS Behav, vol.17, pp.2075-83, 2013.

R. M. Ryan and E. L. Deci, Self-determination theory and the facilitation of intrinsic motivation, social development, and well-being, Am Psychol, vol.55, pp.68-78, 2000.

C. L. Fry and N. Lintzeris, Psychometric properties of the Blood-borne Virus Transmission Risk Assessment Questionnaire (BBV-TRAQ), Addiction, vol.98, pp.171-179, 2003.

B. J. Shelton, G. H. Gilbert, Z. Lu, P. Bradshaw, L. S. Chavers et al., Comparing longitudinal binary outcomes in an observational oral health study, Stat Med, vol.22, pp.2057-70, 2003.

M. P. Carrieri, P. Roux, J. Cohen, I. Ravaux, P. Dellamonica et al., The impact of methadone and buprenorphine on antiretroviral-related symptoms in opioid-dependent HIV-infected individuals: results from the MANIF 2000 cohort study. 5ème Conférence Francophone VIH/SIDA, 2010.

M. P. Carrieri, C. Leport, C. Protopopescu, J. P. Cassuto, E. Bouvet et al., Factors associated with nonadherence to highly active antiretroviral therapy: a 5-year follow-up analysis with correction for the bias induced by missing data in the treatment maintenance phase, J Acquir Immune Defic Syndr, vol.41, pp.477-85, 2006.

S. B. Montgomery, J. Hyde, D. Rosa, C. J. Rohrbach, L. A. Ennett et al., Gender differences in HIV risk behaviors among young injectors and their social network members, Am J Drug Alcohol Abuse, vol.28, pp.453-75, 2002.

E. L. Gollub, D. Rey, Y. Obadia, and J. P. Moatti, Gender differences in risk behaviors among HIV+ persons with an IDU history. The link between partner characteristics and women's higher drug-sex risks. The Manif 2000 Study Group, Sex Transm Dis, vol.25, pp.483-491, 1998.

D. Tracy, J. A. Hahn, C. Fuller-lewis, J. Evans, A. Briceno et al., Higher risk of incident hepatitis C virus among young women who inject drugs compared with young men in association with sexual relationships: a prospective analysis from the UFO Study cohort, BMJ Open, vol.4, 2014.

K. Tassiopoulos, J. Bernstein, and E. Bernstein, Age and sharing of needle injection equipment in a cohort of Massachusetts injection drug users: an observational study, Addict Sci Clin Pract, vol.8, p.20, 2013.

L. Marchand, C. Evans, J. Page, K. Davidson, P. J. Hahn et al., Hazardous alcohol consumption among young adult IDU and its association with high risk behaviors, Drug Alcohol Depend, vol.127, pp.143-152, 2013.

L. Maher, B. Jalaludin, K. G. Chant, R. Jayasuriya, T. Sladden et al., Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia, Addiction, vol.101, pp.1499-508, 2006.

P. De, J. Cox, J. F. Boivin, R. W. Platt, and A. Jolly, Rethinking approaches to risk reduction for injection drug users: differences in drug type affect risk for HIV and hepatitis C virus infection through drug-injecting networks, J Acquir Immune Defic Syndr, vol.46, pp.355-61, 2007.

M. Gossop, J. Marsden, D. Stewart, and S. Treacy, Reduced injection risk and sexual risk behaviours after drug misuse treatment: results from the National Treatment Outcome Research Study, AIDS Care, vol.14, pp.77-93, 2002.

H. M. Colon, R. R. Robles, S. Deren, H. Sahai, H. A. Finlinson et al., Between-city variation in frequency of injection among Puerto Rican injection drug users, J Acquir Immune Defic Syndr, vol.27, pp.405-418, 2001.

A. H. Kral, J. Lorvick, and B. R. Edlin, Sex-and drug-related risk among populations of younger and older injection drug users in adjacent neighborhoods in San Francisco, J Acquir Immune Defic Syndr, vol.24, pp.162-169, 2000.

J. R. Ebright and B. Pieper, Skin and soft tissue infections in injection drug users, Infect Dis Clin North Am, vol.16, pp.697-712, 2002.

S. Mclean, R. Bruno, S. Brandon, and B. De-graaff, Effect of filtration on morphine and particle content of injections prepared from slow-release oral morphine tablets, Harm Reduct J, vol.6, p.37, 2009.

P. Roux, M. P. Carrieri, L. Keijzer, and N. Dasgupta, Reducing harm from injecting pharmaceutical tablet or capsule material by injecting drug users, Drug Alcohol Rev, vol.30, pp.287-90, 2011.

R. Sacks-davis, D. Horyniak, J. Grebely, and M. Hellard, Behavioural interventions for preventing hepatitis C infection in people who inject drugs: a global systematic review, Int J Drug Policy, vol.23, pp.176-84, 2012.

T. Tucker, C. L. Fry, N. Lintzeris, S. Baldwin, A. Ritter et al., Randomized controlled trial of a brief behavioural intervention for reducing hepatitis C virus risk practices among injecting drug users, Addiction, vol.99, pp.1157-66, 2004.

W. A. Zule, E. C. Costenbader, C. M. Coomes, and W. Wechsberg, Effects of a hepatitis C virus educational intervention or a motivational intervention on alcohol use, injection drug use, and sexual risk behaviors among injection drug users, Am J Public Health, vol.99, pp.180-186, 2009.

R. A. Wood, E. Wood, C. Lai, M. W. Tyndall, J. S. Montaner et al., Nurse-delivered safer injection education among a cohort of injection drug users: evidence from the evaluation of Vancouver's supervised injection facility, Int J Drug Policy, vol.19, pp.183-191, 2008.

E. Wood, M. W. Tyndall, Z. Qui, R. Zhang, J. S. Montaner et al., Service uptake and characteristics of injection drug users utilizing North America's first medically supervised safer injecting facility, Am J Public Health, vol.96, pp.770-773, 2006.

S. Darke, Self-report among injecting drug users: a review, Drug Alcohol Depend, vol.51, pp.253-63, 1998.

K. Abel-ollo, M. Rahu, K. Rajaleid, A. Talu, K. Ruutel et al., Knowledge of HIV serostatus and risk behaviour among injecting drug users in Estonia, AIDS Care, vol.21, pp.851-858, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00545374